Cypher drug-eluting stent treatment of tibioperoneal obstructive disease: A case report

被引：3

作者：

Hillegass, WB

Goyal, M

Misra, VK

Jordan, WD

机构：

[1] Univ Alabama, Div Cardiovasc Dis, Birmingham, AL 35294 USA

[2] Univ Alabama, Div Vasc Surg, Birmingham, AL USA

来源：

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS | 2005年 / 64卷 / 02期

关键词：

tibial artery disease; stents; drug-eluting stents;

D O I：

10.1002/ccd.20255

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Stent placement in a tibial artery for suboptimal angioplasty results has had a high rate of restenosis and occlusion due to neointimal hyperplasia. Drug-eluting stents may provide a new therapeutic option in this situation. We describe the use of a Cypher drug-eluting stent after suboptimal angioplasty result in a claudicant with a severe tibioperoneal trunk lesion and single-vessel runoff to the foot with 6-month follow-up. (C) 2005 Wiley-Liss, Inc.

引用

收藏

页码：237 / 241

页数：5

相关论文

共 13 条

[1] PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY OF THE INFRAPOPLITEAL ARTERIES - RESULTS IN 53 PATIENTS [J].

BAKAL, CW ;

SPRAYREGEN, S ;

SCHEINBAUM, K ;

CYNAMON, J ;

VEITH, FJ .

AMERICAN JOURNAL OF ROENTGENOLOGY, 1990, 154 (01) :171-174

[2] Infrapopliteal percutaneous transluminal angioplasty: What we know [J].

Bakal, CW ;

Cynamon, J ;

Sprayregen, S .

RADIOLOGY, 1996, 200 (01) :36-43

[3]

BAKAL CW, 1998, VACULAR INTERVENTION, P179

[4] SUCCESSFUL LIMB SALVAGE AFTER RECANALIZATION OF AN OCCLUDED INFRAPOPLITEAL ARTERY UTILIZING A BALLOON EXPANDABLE (PALMAZ-SCHATZ) STENT [J].

DORROS, G ;

HALL, P ;

PRINCE, C .

CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1993, 28 (01) :83-88

[5] Drug-eluting stents: Potential applications for peripheral arterial occlusive disease [J].

Duda, SH ;

Poerner, TC ;

Wiesinger, B ;

Rundback, JH ;

Tepe, G ;

Wiskirchen, J ;

Haase, KK .

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2003, 14 (03) :291-301

[6] Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease [J].

Duda, SH ;

Pusich, B ;

Richter, G ;

Landwehr, P ;

Oliva, VL ;

Tielbeek, A ;

Wiesinger, B ;

Hak, JB ;

Tielemans, H ;

Ziemer, G ;

Cristea, E ;

Lansky, A ;

Bérégi, JP .

CIRCULATION, 2002, 106 (12) :1505-1509

[7]

Grube Eberhard, 2002, J Interv Cardiol, V15, P471, DOI 10.1111/j.1540-8183.2002.tb01091.x

[8]

Henry M, 1996, J ENDOVASC SURG, V3, P369, DOI 10.1583/1074-6218(1996)003<0369:CEWANN>2.0.CO

[9]

2

[10] Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL) - Sirolimus-eluting stents inhibit restenosis irrespective of the vessel size [J].

Regar, E ;

Serruys, PW ;

Bode, C ;

Holubarsch, C ;

Guermonprez, JL ;

Wijns, W ;

Bartorelli, A ;

Constantini, C ;

Degertekin, M ;

Tanabe, K ;

Disco, C ;

Wuelfert, E ;

Morice, MC .

CIRCULATION, 2002, 106 (15) :1949-1956